A minimal common outcome measure set for COVID-19 clinical research.

The Lancet Infectious Diseases
WHO Working Group on the Clinical Characterisation and Management of COVID-19 infection

Abstract

Clinical research is necessary for an effective response to an emerging infectious disease outbreak. However, research efforts are often hastily organised and done using various research tools, with the result that pooling data across studies is challenging. In response to the needs of the rapidly evolving COVID-19 outbreak, the Clinical Characterisation and Management Working Group of the WHO Research and Development Blueprint programme, the International Forum for Acute Care Trialists, and the International Severe Acute Respiratory and Emerging Infections Consortium have developed a minimum set of common outcome measures for studies of COVID-19. This set includes three elements: a measure of viral burden (quantitative PCR or cycle threshold), a measure of patient survival (mortality at hospital discharge or at 60 days), and a measure of patient progression through the health-care system by use of the WHO Clinical Progression Scale, which reflects patient trajectory and resource use over the course of clinical illness. We urge investigators to include these key data elements in ongoing and future studies to expedite the pooling of data during this immediate threat, and to hone a tool for future needs.

Citations

Jul 28, 2020·JAMA : the Journal of the American Medical Association·Eva PetkovaAndrea B Troxel
Sep 2, 2020·BMC Medical Research Methodology·Shesh N RaiAruni Bhatnagar
Aug 18, 2020·Critical Care Medicine·Nicole EvangelidisUNKNOWN COVID-19-Core Outcomes Set (COS) Survey Investigators
Aug 18, 2020·Critical Care Medicine·Allison TongUNKNOWN COVID-19-Core Outcomes Set (COS) Workshop Investigators
Aug 29, 2020·Journal of Medical Virology·Caterina SagnelliNicola Coppola
Oct 13, 2020·The Cochrane Database of Systematic Reviews·Khai Li ChaiNicole Skoetz
Sep 18, 2020·The Journal of Infectious Diseases·Joana VitteJean-Louis Mege
Oct 21, 2020·JAMA Internal Medicine·Olivier HermineUNKNOWN CORIMUNO-19 Collaborative Group
Nov 1, 2020·The Journal of Infectious Diseases·Lisa HenssBarbara S Schnierle
Nov 25, 2020·The New England Journal of Medicine·Ventura A SimonovichUNKNOWN PlasmAr Study Group
Jul 17, 2020·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Oriol MitjàMartí Vall-Mayans
Sep 16, 2020·Annals of Internal Medicine·Isabelle BoutronUNKNOWN COVID-NMA Consortium
Oct 31, 2020·American Journal of Respiratory and Critical Care Medicine·Michiel SchinkelW Joost Wiersinga
Jan 15, 2021·The Lancet. Respiratory Medicine·Rishi K GuptaUNKNOWN ISARIC4C Investigators
Oct 24, 2020·Transboundary and Emerging Diseases·Denis C BauerSeshadri S Vasan
Dec 9, 2020·La Revue de médecine interne·Q RichierO Hermine
Nov 27, 2020·Frontiers in Pharmacology·Janet SultanaGianluca Trifirò
Feb 12, 2021·Cell·Aurélien SokalMatthieu Mahévas
Nov 15, 2020·Nature Reviews. Endocrinology·Soo LimMichael A Nauck
Jan 16, 2021·The FEBS Journal·Serena ZacchignaLawrence Banks
Feb 9, 2021·Clinical Chemistry and Laboratory Medicine : CCLM·Julien FavresseJonathan Douxfils
Feb 26, 2021·The New England Journal of Medicine·UNKNOWN REMAP-CAP InvestigatorsLennie P G Derde
Jan 16, 2021·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·P Lewis WhiteMatthijs Backs
Feb 27, 2021·JAMA : the Journal of the American Medical Association·Perrine JaniaudLars G Hemkens
Jan 23, 2021·Journal of the American Medical Informatics Association : JAMIA·Michael RoimiUri Shalit

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.